Page last updated: 2024-10-23

berberine and Graft vs Host Disease

berberine has been researched along with Graft vs Host Disease in 2 studies

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Zhao, Y1
Huang, J1
Li, T1
Zhang, S1
Wen, C1
Wang, L1
Wang, M1
Zhang, J1
Zhao, H1
Wan, D1
Jiang, Z1

Other Studies

2 other studies available for berberine and Graft vs Host Disease

ArticleYear
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:4

    Topics: Animals; Berberine; Colon; Gastrointestinal Microbiome; Graft vs Host Disease; Inflammasomes; Mice;

2022
Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.
    International immunopharmacology, 2020, Volume: 81

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Berberine; Bone Marrow Transplantation; Cyclospori

2020